Venture-Med Angel Investment Group is a membership organization of accredited investors dedicated to funding and mentoring new healthcare startup companies. We focus on medical devices, healthcare IT, diagnostic biopharma and digital health technologies that will enhance patient safety and outcomes. Membership Inquiry.
We provide unparalleled access, mentorship and support to early-stage companies that have IP, a strong team, domain expertise and vision. Learn more about our Screening and Evaluation Process.
We are very excited to bring the best healthcare startup companies to light. These are companies that have IP, a seasoned and experienced team and are tackling big problems with innovative solutions. We also bring very knowledgable featured speakers to our events.
View Upcoming Events.
(Reuters Health) - African-American women have worse breast cancer survival than white women in the U.S., and a new study suggests that is largely because black women are less likely to have health insurance. […]
KIEV (Reuters) - Ukrainian lawmakers voted through a long-delayed overhaul of the health system on Thursday that the state's Western backers say will raise standards and tackle a culture of bribe-taking in surgeries and hospitals. […]
(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was developed by Gilead Science Inc's Kite Pharma, marking the second approval for this potentially revolutionary approach to fighting cancer. […]
A potentially life-saving surgical glue that is highly elastic and adhesive can quickly seal wounds in seconds without the need for common staples or sutures. The surgical glue, called MeTro, is a development from biomedical engineers at the University of Sydney and biomedical engineers from Harvard University. MeTro has a high elasticity that can seal […] T […]
Artificial intelligence could improve detection and diagnosis of breast cancer and eliminate false positives, according to new research out of the Massachusetts Institute of Technology’s Computer Science and Artificial Intelligence Laboratory (CSAIL). A team of researchers from MIT’s CSAIL, Massachusetts General Hospital and Harvard Medical School developed […]
With Gilead Sciences (NSDQ:GILD) and Novartis (NYSE:NVS) leading the way, cell therapies are moving on to the market and into the clinics for patients that have no other option. Companies making CAR-T therapies use a patient’s own cells to genetically engineer a cancer-killing cellular therapy that is then delivered back to the patient. And one 55-person com […]
Varian Medical (NYSE:VAR) said today it launched its Halcyon image-guided volumetric intensity modulated radiotherapy cancer treatment system in the European Union, with the 1st patient being treated in Blegium. The Palo Alto, Calif.-based company said its Halcyon IMRT system features improvements that make it more comfortable for patients and streamline ope […]
...fertility benefits to employees. And, as a result, better patient outcomes." Currently, Chairman of the Board of the Center for Healthcare Innovation, he is also Managing Director of Rosen Biosciences Strategies LLC, a life science economic development consultancy. Previously, he spent ... […]
...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. View source version on businesswire.com: http://www.businesswire.com/news/home/20171016006199/en/ [ Back ... […]
...WeFund Health WeFund Health is a disruptive health technology investment platform that intelligently matches HealthTech opportunities with qualified investors and healthcare innovation centers around the world. WeFund Health provides a transparent vehicle for deal assessment in a controlled environment, matching each ... […]